These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22830212)

  • 1. [Survival of gout patients].
    Ter Arkh; 2012; 84(5):45-50. PubMed ID: 22830212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gout: an independent risk factor for all-cause and cardiovascular mortality.
    Kuo CF; See LC; Luo SF; Ko YS; Lin YS; Hwang JS; Lin CM; Chen HW; Yu KH
    Rheumatology (Oxford); 2010 Jan; 49(1):141-6. PubMed ID: 19933595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term cardiovascular mortality among middle-aged men with gout.
    Krishnan E; Svendsen K; Neaton JD; Grandits G; Kuller LH;
    Arch Intern Med; 2008 May; 168(10):1104-10. PubMed ID: 18504339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperuricemia, gout, and cardiovascular disease--an important "muddle".
    Keenan RT; Pillinger MH
    Bull NYU Hosp Jt Dis; 2009; 67(3):285-90. PubMed ID: 19852752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.
    Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E;
    Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.
    Karha J; Bavry AA; Rajagopal V; Henderson MR; Ellis SG; Brener SJ
    Am J Cardiol; 2006 Sep; 98(5):616-8. PubMed ID: 16923447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insulin resistance syndrome in patients with gout and its influence on formation of clinical characteristics of the disease].
    Barskova VG; Eliseev MS; Nasonov EL; Iakunina IA; Zilov AV; Il'inykh EV
    Ter Arkh; 2004; 76(5):51-6. PubMed ID: 15230133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk.
    van der Zee PM; Cornel JH; Bholasingh R; Fischer JC; van Straalen JP; De Winter RJ
    Am J Med; 2011 Oct; 124(10):961-9. PubMed ID: 21962317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent impact of gout on mortality and risk for coronary heart disease.
    Choi HK; Curhan G
    Circulation; 2007 Aug; 116(8):894-900. PubMed ID: 17698728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation, residual kidney function, and cardiac hypertrophy are interrelated and combine adversely to enhance mortality and cardiovascular death risk of peritoneal dialysis patients.
    Wang AY; Wang M; Woo J; Lam CW; Lui SF; Li PK; Sanderson JE
    J Am Soc Nephrol; 2004 Aug; 15(8):2186-94. PubMed ID: 15284304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C- Reactive protein, cardiac troponin T and low albumin are predictors of mortality in hemodialysis patients.
    Bagheri N; Taziki O; Falaknazi K
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):789-93. PubMed ID: 19736474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients.
    Boulier A; Jaussent I; Terrier N; Maurice F; Rivory JP; Chalabi L; Boularan AM; Delcourt C; Dupuy AM; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2004 Sep; 19(9):2313-8. PubMed ID: 15252159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild depression versus C-reactive protein as a predictor of cardiovascular death: a three year follow-up of patients with stable coronary artery disease.
    Rallidis LS; Varounis C; Sourides V; Charalampopoulos A; Kotakos C; Liakos G; Dagres N; Apostolou T; Anastasiou-Nana M
    Curr Med Res Opin; 2011 Jul; 27(7):1407-13. PubMed ID: 21568834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V; Winkler K; Drechsler C; Lilienthal J; März W; Wanner C;
    Am J Kidney Dis; 2009 Nov; 54(5):902-11. PubMed ID: 19781835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure.
    Johansson M; Gao SA; Friberg P; Annerstedt M; Carlström J; Ivarsson T; Jensen G; Ljungman S; Mathillas O; Nielsen FD; Strömbom U
    J Hypertens; 2007 Jan; 25(1):163-8. PubMed ID: 17143188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ischemic stroke history predicts increased cardiovascular mortality in chronic heart failure.
    Kozdağ G; Yaymacı M; Işeri P; Ertaş G; Emre E; Bildirici U; Kılıç T; Ural D
    Anadolu Kardiyol Derg; 2011 Aug; 11(5):421-7. PubMed ID: 21712170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
    Anavekar NS; McMurray JJ; Velazquez EJ; Solomon SD; Kober L; Rouleau JL; White HD; Nordlander R; Maggioni A; Dickstein K; Zelenkofske S; Leimberger JD; Califf RM; Pfeffer MA
    N Engl J Med; 2004 Sep; 351(13):1285-95. PubMed ID: 15385655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia, gout and the metabolic syndrome.
    Puig JG; Martínez MA
    Curr Opin Rheumatol; 2008 Mar; 20(2):187-91. PubMed ID: 18349749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gout and the risk of acute myocardial infarction.
    Krishnan E; Baker JF; Furst DE; Schumacher HR
    Arthritis Rheum; 2006 Aug; 54(8):2688-96. PubMed ID: 16871533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.